Oceania Healthcare (OCA)•HY26•Released 21 November 2025OCA swung to PBT positive but capex jumped 82% to 40.4% of revenueEBITDA rose 7.4% on flat revenue and PBT turned positive at $1.0m, but a doubled investment cycle kept free cash flow at -$8.4m.Published 21 April 2026Read briefing→
Oceania Healthcare (OCA)•FY25•Released 22 May 2025Capex jumped 354% to $132.4m, pushing FCF to -$22.1mEBITDA rose 4.1% and a tax credit held NPAT, but a major capex step-up consumed operating cash and net debt sits at 7.2x EBITDA.Published 22 April 2026Read briefing→
Oceania Healthcare (OCA)•HY25•Released 22 November 2024Underlying EBITDA up 2.7% but reported result swung to NZ$17.1m NPAT lossOperating cash flow surged on a NZ$101m receivables collection while items below EBITDA pushed PBT down 160.3% to a NZ$19.5m loss.Published 22 April 2026Read briefing→
Oceania Healthcare (OCA)•FY24•Released 24 May 2024Capex cut 68% to manage 7.7x leverage; tax benefit inflated NPATEBITDA rose just 3.2% on 7.4% revenue growth, while a -10.9% effective tax rate drove NPAT up 104.5% and development capex was paused.Published 22 April 2026Read briefing→
Oceania Healthcare (OCA)•HY24•Released 22 November 2023NPAT swung to NZ$35.2m but trade debtors expanded NZ$110.5mUnderlying EBITDA held near NZ$37.6m, but receivables expanded NZ$110.5m and debtor days hit 168.5 against a historical mean of 22.7 days.Published 22 April 2026Read briefing→
Oceania Healthcare (OCA)•FY23•Released 24 May 2023Net debt/EBITDA jumped to 6.9x as operating cash fell 33%Revenue grew 6.9% and care swung to profit, but borrowings rose $177.9m and a $86.9m receivables build absorbed underlying cash generation.Published 22 April 2026Read briefing→
Oceania Healthcare (OCA)•HY23•Released 7 November 2022PBT fell 74.3% on lower Village revaluations as cash conversion slidRealised sales gains rose 12%, but cash conversion dropped to 81.2% and the 1.9c dividend exceeds NPAT cover.Published 22 April 2026Read briefing→